Celiac Disease Foundation Impact Fund
◆ Fund Size
$15M
◆ Location
United States
◆ Activity
Statusraising
◆ Links
◆ Share this fund
◆ Investment Thesis
A venture philanthropy fund designed to accelerate innovation across the celiac disease ecosystem by investing in early detection, prevention, education, and curative breakthroughs.
◆ About Celiac Disease Foundation
The Celiac Disease Foundation Impact Fund is a mission-driven venture philanthropy fund focused on companies that can accelerate detection, prevention, education, and treatment of celiac disease. It uses catalytic capital alongside venture-style diligence to support scalable innovations across diagnostics, biomarkers, microbiome and immune-modulating therapies, education tools, and potential cures.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Brett Spitale | Chief Advancement Officer | senior | |
| Gregg Stein | — | senior | |
| Triple G Ventures | Investment manager / partner | — | |
| Triple G Ventures team | Investment manager | senior |
◆ Traits
Co-invests
◆ FAQ
What does Celiac Disease Foundation Impact Fund invest in?
Celiac Disease Foundation Impact Fund invests in Biotech, Diagnostics, Digital Health, Drug Discovery and Medtech at the seed and series-a stages.
Which geographies does Celiac Disease Foundation Impact Fund focus on?
Celiac Disease Foundation Impact Fund focuses on worldwide, and is headquartered in United States.